Major, Ajay;
Palese, Monica;
Ermis, Ebru;
James, Anthony;
Villarroel, Milena;
Klussmann, Federico Antillon;
Hessissen, Laila;
... Volchenboum, Samuel L; + view all
(2022)
Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.
JCO Global Oncology
, 8
(8)
, Article e2100266. 10.1200/GO.21.00266.
Preview |
Text
Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.pdf - Published Version Download (444kB) | Preview |
Preview |
Text
Figure 1.pdf - Accepted Version Download (163kB) | Preview |
Abstract
PURPOSE: The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer. METHODS: A narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia. RESULTS: There is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships. CONCLUSION: There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.
| Type: | Article |
|---|---|
| Title: | Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1200/GO.21.00266 |
| Publisher version: | https://doi.org/10.1200/GO.21.00266 |
| Language: | English |
| Additional information: | © 2022 American Society of Clinical Oncology. Original content in this article is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10144339 |
Archive Staff Only
 |
View Item |
